ConductScience.org, home
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
API referenceFor AI assistants

Trial · NCT00968708

Adverse events1,464

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

561 to 580 of 1,464

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousObstructive uropathyRenal and urinary disordersPlacebo02,679
seriousObstructive uropathyRenal and urinary disordersAlogliptin12,701
seriousRenal embolismRenal and urinary disordersPlacebo12,679
seriousRenal embolismRenal and urinary disordersAlogliptin02,701
seriousRenal injuryRenal and urinary disordersPlacebo02,679
seriousRenal injuryRenal and urinary disordersAlogliptin12,701
seriousRenal massRenal and urinary disordersPlacebo12,679
seriousRenal massRenal and urinary disordersAlogliptin02,701
seriousUreteric obstructionRenal and urinary disordersPlacebo12,679
seriousUreteric obstructionRenal and urinary disordersAlogliptin02,701
seriousUrinary incontinenceRenal and urinary disordersPlacebo02,679
seriousUrinary incontinenceRenal and urinary disordersAlogliptin12,701
seriousUrinary tract obstructionRenal and urinary disordersPlacebo02,679
seriousUrinary tract obstructionRenal and urinary disordersAlogliptin12,701
seriousAcute pulmonary oedemaRespiratory, thoracic and mediastinal disordersPlacebo152,679
seriousAcute pulmonary oedemaRespiratory, thoracic and mediastinal disordersAlogliptin242,701
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersPlacebo192,679
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersAlogliptin132,701
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersPlacebo152,679
seriousPulmonary oedemaRespiratory, thoracic and mediastinal disordersAlogliptin132,701

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=29

API referenceFor AI assistants